These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Pefakit® TAFI is a plasma-based chromogenic test for the determination of TAFI activity.
2 x 4.0 mL
The Safety Data Sheets and Notices are accessible to our registered customers.
TAFI, thrombin-activatable fibrinolytic inhibitor, (also known as carboxypeptidase U and plasma pro-carboxypeptidase B) is a 60kDa molecular weight glycoprotein (proenzyme form) found in human plasma that modulates fibrinolysis.
This proenzyme is converted to an active form of molecular ratio 35kDa, TAFIa, after proteolytic cleavage by the thrombin / thrombomodulin complex. TAFIa possesses carboxypeptidase activity with a preference for cleavage of lysine and arginine residues from the end of proteins.
Calibrator and control plasma delivered in a separate test kit (Pefakit® TAFI Calibrator and Controls, Code 8-800187).
Inserts and certificates of analysis provided.
Safety data sheets (SDS) provided.
- 2 vials of lyophilized activator, to be reconstituted in 4.0 mL of demineralized water.
- 2 vials of lyophilized reagent, to be reconstituted in 4.0 mL of diluent.
- 2 vials of ready-to-use diluent for reconstitution of the reagent.